EAM Investors, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 155 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$4,169,000
+226.0%
219,415
+181.3%
0.69%
+203.1%
Q4 2017$1,279,000
-60.0%
77,999
-63.4%
0.23%
-46.1%
Q3 2017$3,195,000
+225.7%
213,027
+91.1%
0.42%
+162.3%
Q2 2017$981,000
+14.1%
111,486
+18.4%
0.16%
+44.6%
Q4 2015$860,000
-8.0%
94,183
+53.8%
0.11%
-36.7%
Q2 2014$935,000
-34.5%
61,248
-22.4%
0.18%
-31.1%
Q1 2014$1,427,000
+2.8%
78,938
-21.0%
0.26%
+3.6%
Q4 2013$1,388,00099,8930.25%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Rokos Capital Management LLP 6,474,348$11,394,8520.84%
WASATCH ADVISORS LP 13,642,417$24,010,6540.15%
Avidity Partners Management LP 2,470,000$4,347,2000.14%
Acrisure Capital Management, LLC 75,832$133,4640.14%
Golden State Equity Partners 135,765$238,9460.13%
Long Focus Capital Management, LLC 1,072,000$1,886,7200.11%
KLK CAPITAL MANAGEMENT LLC 44,323$78,0080.10%
CAXTON ASSOCIATES LP 288,218$507,2640.08%
XTX Topco Ltd 206,334$363,1480.08%
Rhenman & Partners Asset Management AB 314,157$534,0670.06%
View complete list of SANGAMO THERAPEUTICS INC shareholders